MedPath

Comparing the effects of intravenous ephedrine, of muscular ephedrine and of intradermal ephedrine in preventing hypotensio

Phase 2
Conditions
Hypotension induced by injection of intravenous ephedrine, of muscular ephedrine and of intradermal ephedrine.
Hypotension due to drugs
Registration Number
IRCT2015092824233N1
Lead Sponsor
Vice chancellor for research, Jahrom University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
96
Inclusion Criteria

20 to 30years old mothers who participate in class 1 and 2 ASA; tend to have spinal anesthesia; do not have a base systolic blood pressure more than 130 mmHg and less than 90 mmHg; do not have a history of high blood pressure and are consciously willing to participate in the project. Exclusion criteria: participants in class 3 and 4 ASA; patients with cardiovascular disease; people with tachycardia (over 100 beats per minute) and with bradycardia (less than 60 beats per minute); any history of hypertension, diabetes mellitus; patients with thyroid disease, using beta-agonists and beta blockers; preterm delivery; using banned drugs during pregnancy; preeclampsia and pre-eclampsia and eclampsia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Every 2.5 minutes to 10 minutes and then until 45 minutes every 5 minutes. Method of measurement: mmHg.
Secondary Outcome Measures
NameTimeMethod
ausea and vomiting. Timepoint: every 15 minutes. Method of measurement: Scale Alderet.;Shivering. Timepoint: Every 15 minutes. Method of measurement: Scale rossely & mahajan.
© Copyright 2025. All Rights Reserved by MedPath